ID
20421
Beskrivning
The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1
Länk
https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1
Nyckelord
Versioner (1)
- 2017-02-22 2017-02-22 -
Uppladdad den
22 februari 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Trial Completion PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
Trial Completion PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
Beskrivning
Invenstigator´s Declaration
Alias
- UMLS CUI-1
- C0008961
Beskrivning
Invenstigator´s Declaration
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0008961
- UMLS CUI [1,2]
- C1442085
Beskrivning
Investigator´s signature
Datatyp
text
Alias
- UMLS CUI [1]
- C2346576
Beskrivning
Date of Signature
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C1519316
Similar models
Trial Completion PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
C0040223 (UMLS CUI [1,2])
C1442085 (UMLS CUI [1,2])
C1519316 (UMLS CUI [1,2])
Inga kommentarer